ICON Web & News
Virtual Journal
Everything
Resources
Virtual Journal
Analyze Database
GoodNanoGuide
ICON Reports
ICON Backgrounders
Glossary
Policy Reports
Ratings Comment
Guidelines
Links
Quick Search:
Keywords:
Search:
Search Using OECD Database
Details
Return to Previous Page
Addition or Correction
Title:
In Vivo Biodistribution, Pharmacokinetics, and Toxicology of Carbon Nanotubes
Date:
10/2012
Link to Journal Abstract
Abstract:
Owing to their interesting physical and chemical properties, carbon nanotubes (CNTs) have attracted wide attentions in nanomedicine for applications in biological sensing, drug delivery, as well as biomedical imaging. The in vivo behaviors and toxicology of CNTs in biological systems, which are important fundamental questions, although have been intensively studied in recent years, remain to be clarified as distinctive results have been reported by various teams, confusing the scientific community as well as the public. In this article, we review the research on the in vivo behaviors of CNTs, and summarize the toxicity studies of CNTs in animals by different groups. Similar to other nanomaterials, the in vivo pharmacokinetics and biodistribution of CNTs are closely associated with their surface coatings. The excretion of CNTs from animals may happen via renal and fecal pathways, depending on the CNT surface chemistry, shape, and sizes. Regarding the toxicology of CNTs, which has been a debating topic for years, the administration routes, doses, and again the surface functionalization are critical to the in vivo toxicity of nanotubes. Much more efforts are still required to develop functional CNT bioconjugates with improved biocompatible coatings and controllable optimal sizes to achieve fast excretion and minimal toxicity, for various applications in biomedicine.
Non-technical Summary:
In this paper, the authors review the research on the in vivo behaviors of carbon nanotubes (CNTs), and summarize the toxicity studies of CNTs in animals by different groups.
Content Emphasis
Review Article
Exposure Or Hazard Target
Mammalian
Exposure Pathway
Other/Unspecified
Method Of Study
Multiple
Paper Type
Hazard
Particle Type
Carbon
Production Method
Engineered
Risk Exposure Group
General Population
Target Audience
Technical Research
Citation:
Current Drug Metabolism, 13(8): 1057-1067 (October 2012)
Publication:
Current Drug Metabolism
Author:
Yang K, Liu Z
Volume:
13
Number:
8
Pages:
1057-1067
Last updated on November 6, 2012
Permalink
Join Us
|
About
|
Newsroom
|
Working Groups
|
Projects
|
Resources
|
Virtual Journal
|
Events
|
Logout
This work is supported in part by the Nanoscale Science and Engineering Initiative of the National Science Foundation
under NSF Award Number EEC-0118007.
Why Join Us?
Mission and Strategy
Background
Organization
Sponsors
Participants
Contact Us
ICON Releases
News
Media Alert
RSS
Governance
Knowledge Base
Best Practices
Communications
Virtual Journal
Analyze Database
Good Nano Guide
ICON Reports
ICON Backgrounders
Glossary
Policy Reports
Links
Council Events
Other Events
Virtual Journal
Analyze Database
The GoodNanoGuide
Nano EHS Research Needs
Current Practices Survey